[1]
K. S. Gunturu, M. Abu-Khalaf, and M. W. Saif, “Hepatic Failure and Hepatorenal Syndrome Secondary to Erlotinib: A Possible Etiology of Complications in a Patient with Pancreatic Cancer”, JOP. J Pancreas (Online), vol. 11, no. 5, pp. 484–485, Sep. 2010.